Lexicon Pharmaceuticals, Inc(NASDAQ:LXRX) 
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the t...
Website: http://www.lexpharma.com
Founded: 1995
Full Time Employees: 184
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.41
H 0.46
L 0.41
C 0.42
V 10,830,552
10EMA 0.42
20EMA 0.42
60EMA 0.42
120EMA 0.42
250EMA 0.42